Skip to Main content

Social networks

Co-authors

Number of documents

19

Articles


 

Laurie Galvan, Elizabeth Wang, Carlos Cepeda, Michael Levine. Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. Journal of Huntington's Disease, 2012, 1 (1), pp.17-25. ⟨10.3233/JHD-2012-120009⟩⟨hal-02459788⟩  
Sandra Holley, Laurie Galvan, Talia Kamdjou, Carlos Cepeda, Michael Levine. Striatal GABA ergic interneuron dysfunction in the Q175 mouse model of Huntington's disease. European Journal of Neuroscience, Wiley, 2018, ⟨10.1111/ejn.14283⟩⟨hal-02459725⟩  
Sandra Holley, Prasad Joshi, Anna Parievsky, Laurie Galvan, Jane Chen, et al.. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease. eNeuro, Society for Neuroscience, 2015, 2 (1), pp.ENEURO.0008-14.2015. ⟨10.1523/ENEURO.0008-14.2015⟩⟨hal-02459863⟩  
Jane Chen, Elizabeth Wang, Laurie Galvan, My Huynh, Prasad Joshi, et al.. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLoS Currents, Public Library of Science, 2013, ⟨10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202⟩⟨hal-02459786⟩  
Jamee m. Berg, Changhoon Lee, Leslie Chen, Laurie Galvan, Carlos Cepeda, et al.. JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse. Neuron, Elsevier, 2015, 88 (6), pp.1173-1191. ⟨10.1016/j.neuron.2015.10.031⟩⟨hal-02459747⟩  
Maria Damiano, Laurie Galvan, Nicole Déglon, Emmanuel Brouillet. Mitochondria in Huntington's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802 (1), pp.52-61. ⟨10.1016/j.bbadis.2009.07.012⟩⟨hal-02459756⟩  
Laetitia Francelle, Laurie Galvan, Emmanuel Brouillet. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Frontiers in Cellular Neuroscience, Frontiers, 2014, ⟨10.3389/fncel.2014.00295⟩⟨hal-02459873⟩  
Maria Damiano, Laurie Galvan, Nicole Déglon, Emmanuel Brouillet. Mitochondria in Huntington's disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2009, 1802 (1), pp.52. ⟨10.1016/j.bbadis.2009.07.012⟩⟨hal-00543005⟩  
Julie Espallergues, Laurie Galvan, Laurence Lepourry, Béatrice Bonafos, Tangui Maurice, et al.. Hyposensitivity to the amnesic effects of scopolamine or amyloid β25–35 peptide in heterozygous acetylcholinesterase knockout (AChE+/−) mice. Chemico-Biological Interactions, Elsevier, 2008, 175 (1-3), pp.131-134. ⟨10.1016/j.cbi.2008.04.001⟩⟨hal-02459753⟩  
Laurie Galvan, Nad'A Lepejová, Marie-Claude Gaillard, Carole Malgorn, Martine Guillermier, et al.. Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiology of Aging, Elsevier, 2012, 33 (8), pp.1845.e5-1845.e6. ⟨10.1016/j.neurobiolaging.2012.01.009⟩⟨hal-02459764⟩  
Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoît Bernay, et al.. Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo.. Neurobiology of Aging, Elsevier, 2015, pp.1601.e7-16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩⟨hal-01465910⟩  
Maria Damiano, Elsa Diguet, Carole Malgorn, Marilena d'Aurelio, Laurie Galvan, et al.. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics, Oxford University Press (OUP), 2013, 22 (19), pp.3869-3882. ⟨10.1093/hmg/ddt242⟩⟨hal-02459752⟩  
Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Martine Guillermier, Diane Houitte, et al.. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Human Molecular Genetics, Oxford University Press (OUP), 2015, 24 (6), pp.1563-1573. ⟨10.1093/hmg/ddu571⟩⟨hal-02459748⟩  
Julie Espallergues, Laurie Galvan, Florence Sabatier, Vanessa Rana-Poussine, Tangui Maurice, et al.. Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/−) mice showed no memory enhancement but hyposensitivity to amnesic drugs. Behavioural Brain Research, Elsevier, 2010, 206 (2), pp.263-273. ⟨10.1016/j.bbr.2009.09.024⟩⟨hal-02459760⟩  
Laurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, Lucie de Longprez, Maria-Angeles Carrillo-de Sauvage, et al.. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (5), pp.1434-1454. ⟨10.1093/brain/awy057⟩⟨hal-02074093⟩  
Lydie Boussicault, Sandro Alves, Antonin Lamaziere, Anabelle Planques, Nicolas Heck, et al.. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 139 (3), pp.953-970. ⟨10.1093/brain/awv384⟩⟨hal-02459777⟩  
Laurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, Lucie de Longprez, Maria-Angeles Carrillo-de Sauvage, et al.. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (5), pp.1434-1454. ⟨10.1093/brain/awy057⟩⟨hal-02459743⟩  
Sandra Holley, Prasad Joshi, Anna Parievsky, Laurie Galvan, Jane Chen, et al.. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease. eNeuro, Society for Neuroscience, 2015, 2 (1), pp.ENEURO.0008-14.2015. ⟨10.1523/ENEURO.0008-14.2015⟩⟨hal-02459736⟩  
Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoit Bernay, et al.. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiology of Aging, Elsevier, 2015, 36 (3), pp.1601.e7-1601.e16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩⟨hal-02459770⟩  
Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoit Bernay, et al.. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiology of Aging, Elsevier, 2015, 36 (3), pp.1601.e7-1601.e16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩⟨hal-02459767⟩  
Lydie Boussicault, Sandro Alves, Antonin Lamazière, Anabelle Planques, Nicolas Heck, et al.. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 139 (3), pp.953-970. ⟨10.1093/brain/awv384⟩⟨hal-01299208⟩


Journal articles19 documents

  • Emmanuel Matas, Alexandre Maisterrena, Mathieu Thabault, Eric Balado, Maureen Francheteau, et al.. Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model. Molecular Autism, BioMed Central, 2021, 12 (1), pp.2. ⟨10.1186/s13229-020-00412-8⟩. ⟨hal-03150112⟩
  • Laurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, Lucie de Longprez, Maria-Angeles Carrillo-de Sauvage, et al.. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (5), pp.1434-1454. ⟨10.1093/brain/awy057⟩. ⟨hal-02074093⟩
  • Laurie Galvan, Laetitia Francelle, Marie-Claude Gaillard, Lucie de Longprez, Maria-Angeles Carrillo-de Sauvage, et al.. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain - A Journal of Neurology , Oxford University Press (OUP), 2018, 141 (5), pp.1434-1454. ⟨10.1093/brain/awy057⟩. ⟨hal-03060272⟩
  • Sandra Holley, Laurie Galvan, Talia Kamdjou, Carlos Cepeda, Michael Levine. Striatal GABA ergic interneuron dysfunction in the Q175 mouse model of Huntington's disease. European Journal of Neuroscience, Wiley, 2018, ⟨10.1111/ejn.14283⟩. ⟨hal-02459725⟩
  • Lydie Boussicault, Sandro Alves, Antonin Lamazière, Anabelle Planques, Nicolas Heck, et al.. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 139 (3), pp.953-970. ⟨10.1093/brain/awv384⟩. ⟨hal-01299208⟩
  • Sandra Holley, Prasad Joshi, Anna Parievsky, Laurie Galvan, Jane Chen, et al.. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease. eNeuro, Society for Neuroscience, 2015, 2 (1), pp.ENEURO.0008-14.2015. ⟨10.1523/ENEURO.0008-14.2015⟩. ⟨hal-02459736⟩
  • Sandra Holley, Prasad Joshi, Anna Parievsky, Laurie Galvan, Jane Chen, et al.. Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease. eNeuro, Society for Neuroscience, 2015, 2 (1), pp.ENEURO.0008-14.2015. ⟨10.1523/ENEURO.0008-14.2015⟩. ⟨hal-02459863⟩
  • Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoît Bernay, et al.. Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo.. Neurobiology of Aging, Elsevier, 2015, pp.1601.e7-16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩. ⟨hal-01465910⟩
  • Laetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, Fanny Petit, Benoit Bernay, et al.. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiology of Aging, Elsevier, 2015, 36 (3), pp.1601.e7-1601.e16. ⟨10.1016/j.neurobiolaging.2014.11.014⟩. ⟨hal-02459770⟩
  • Jamee m. Berg, Changhoon Lee, Leslie Chen, Laurie Galvan, Carlos Cepeda, et al.. JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse. Neuron, Elsevier, 2015, 88 (6), pp.1173-1191. ⟨10.1016/j.neuron.2015.10.031⟩. ⟨hal-02459747⟩
  • Laetitia Francelle, Laurie Galvan, Emmanuel Brouillet. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Frontiers in Cellular Neuroscience, Frontiers, 2014, ⟨10.3389/fncel.2014.00295⟩. ⟨hal-02459873⟩
  • Jane Chen, Elizabeth Wang, Laurie Galvan, My Huynh, Prasad Joshi, et al.. Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease. PLoS Currents, Public Library of Science, 2013, ⟨10.1371/currents.hd.ec3547da1c2a520ba959ee7bf8bdd202⟩. ⟨hal-02459786⟩
  • Maria Damiano, Elsa Diguet, Carole Malgorn, Marilena d'Aurelio, Laurie Galvan, et al.. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics, Oxford University Press (OUP), 2013, 22 (19), pp.3869-3882. ⟨10.1093/hmg/ddt242⟩. ⟨hal-02459752⟩
  • Laurie Galvan, Nad'A Lepejová, Marie-Claude Gaillard, Carole Malgorn, Martine Guillermier, et al.. Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiology of Aging, Elsevier, 2012, 33 (8), pp.1845.e5-1845.e6. ⟨10.1016/j.neurobiolaging.2012.01.009⟩. ⟨hal-02459764⟩
  • Laurie Galvan, Elizabeth Wang, Carlos Cepeda, Michael Levine. Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. Journal of Huntington's Disease, 2012, 1 (1), pp.17-25. ⟨10.3233/JHD-2012-120009⟩. ⟨hal-02459788⟩
  • Julie Espallergues, Laurie Galvan, Florence Sabatier, Vanessa Rana-Poussine, Tangui Tm Maurice, et al.. Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/−) mice showed no memory enhancement but hyposensitivity to amnesic drugs. Behavioural Brain Research, Elsevier, 2010, 206 (2), pp.263-273. ⟨10.1016/j.bbr.2009.09.024⟩. ⟨hal-02459760⟩
  • Maria Damiano, Laurie Galvan, Nicole Déglon, Emmanuel Brouillet. Mitochondria in Huntington's disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2010, 1802 (1), pp.52-61. ⟨10.1016/j.bbadis.2009.07.012⟩. ⟨hal-02459756⟩
  • Maria Damiano, Laurie Galvan, Nicole Déglon, Emmanuel Brouillet. Mitochondria in Huntington's disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2009, 1802 (1), pp.52. ⟨10.1016/j.bbadis.2009.07.012⟩. ⟨hal-00543005⟩
  • Julie Espallergues, Laurie Galvan, Laurence Lepourry, Béatrice Bonafos, Tangui Tm Maurice, et al.. Hyposensitivity to the amnesic effects of scopolamine or amyloid β25–35 peptide in heterozygous acetylcholinesterase knockout (AChE+/−) mice. Chemico-Biological Interactions, Elsevier, 2008, 175 (1-3), pp.131-134. ⟨10.1016/j.cbi.2008.04.001⟩. ⟨hal-02459753⟩